Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126242831 | 12624283 | 1 | I | 20160728 | 20160805 | 20160805 | EXP | DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-063790 | BRISTOL MYERS SQUIBB | 0.00 | Y | 0.00000 | 20160805 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126242831 | 12624283 | 1 | PS | ELIQUIS | APIXABAN | 1 | Unknown | 2.5 MG, UNK | U | 202155 | 2.5 | MG | |||||||
| 126242831 | 12624283 | 2 | SS | ASPIRIN. | ASPIRIN | 1 | Unknown | 100 MG, UNK | U | 0 | 100 | MG | |||||||
| 126242831 | 12624283 | 3 | SS | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Unknown | 75 MG, UNK | U | 0 | 75 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126242831 | 12624283 | 1 | Product used for unknown indication |
| 126242831 | 12624283 | 2 | Product used for unknown indication |
| 126242831 | 12624283 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126242831 | 12624283 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126242831 | 12624283 | Off label use | |
| 126242831 | 12624283 | Stent placement |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |